You are here: Industry Insights > AstraZeneca

News List

Emergent expands Covid-19 vaccine manufacturing deal with AstraZeneca pharmaceutical-technology
July 29, 2020
Emergent BioSolutions has entered into an agreement valued at approximately $174m for large-scale commercial production of drug substance for AstraZeneca Covid-19 vaccine candidate, AZD1222.
AstraZeneca signs $6bn worth cancer asset deal with Daiichi Sankyo pharmaceutical-technology
July 28, 2020
AstraZeneca has signed a new agreement to develop and commercialise Japanese company Daiichi Sankyo’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC), DS-1062, globally for various tumour types.
SGS Signs Analytical Testing Agreement with AstraZeneca contractpharma
July 28, 2020
Will provide safety, quality control and analytical testing services in support of a COVID-19 vaccine candidate AZD1222.
Interim data shows strong responses to AZ/Oxford Uni's COVID-19 vaccine pharmatimes
July 22, 2020
A vaccine against SARS-CoV-2 being developed by AstraZeneca and the University of Oxford is showing strong promise in clinical trials.
Oxford COVID-19 vaccine developer cautious on 2020 roll-out expresspharma
July 22, 2020
The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, preserving hopes it could be in use by the end of 2020.
Serum to apply for local trials on Oxford’s vaccine in a week: CEO expresspharma
July 22, 2020
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.
AZ' Farxiga fast-tracked for heart failure following MI pharmatimes
July 20, 2020
AstraZeneca's Farxiga (dapagliflozin) has been granted a Fast Track Designation in the US for reducing the risk of hospitalisation for heart failure (hHF) or cardiovascular (CV) death in adults following an acute myocardial infarction (MI) or heart attack
IQVIA Partners with AstraZeneca contractpharma
July 17, 2020
IQVIA has announced a collaboration with AstraZeneca to accelerate development of a potential new vaccine for COVID-19.
J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine expresspharma
July 17, 2020
J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority.
AZ unveils detailed data from THALES trial pharmatimes
July 16, 2020
AstraZeneca has now shared detailed results from the Phase III THALES, showing that a combination of twice daily Brilinta (ticagrelor) and daily aspirin reduced the rate of stroke and death (the composite primary endpoint) by 17% after 30 days ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page